Interleukin-2 and interferon α 2 combination: Ineffectiveness of a single six-week course in patients with metastatic renal cancer pretreated with interferon alone

Paolo Pronzato

Interleukin-2 and interferon α 2 combination: Ineffectiveness of a single six-week course in patients with metastatic renal cancer pretreated with interferon alone

A.O.U. San Martino - IST, Istituto Nazionale Ricerca sul Cancro (GENOVA)

Research output: Contribution to journal › Article › peer-review

Abstract

We have studied activity and toxicity of subcutaneous recombinant interleukin-2 and interferon α 2b in a series of 14 patients with advanced renal cell carcinoma. No objective response was observed, and the median survival was 16 months (range 3-19); toxicity was acceptable. All the patients had poor prognostic factors and were pretreated with interferon.

Original language	English
Pages (from-to)	1137-1139
Number of pages	3
Journal	Oncology Reports
Volume	3
Issue number	6
Publication status	Published - 1996

Keywords

interferon α
interleukin-2
renal cancer

ASJC Scopus subject areas

Cancer Research
Oncology

Cite this

@article{a672cba49b5e4b13b1d272479144cf8d,

title = "Interleukin-2 and interferon α 2 combination: Ineffectiveness of a single six-week course in patients with metastatic renal cancer pretreated with interferon alone",

abstract = "We have studied activity and toxicity of subcutaneous recombinant interleukin-2 and interferon α 2b in a series of 14 patients with advanced renal cell carcinoma. No objective response was observed, and the median survival was 16 months (range 3-19); toxicity was acceptable. All the patients had poor prognostic factors and were pretreated with interferon.",

keywords = "interferon α, interleukin-2, renal cancer",

author = "Paolo Pronzato",

year = "1996",

language = "English",

volume = "3",

pages = "1137--1139",

journal = "Oncology Reports",

issn = "1021-335X",

publisher = "Spandidos Publications",

number = "6",

}

TY - JOUR

T1 - Interleukin-2 and interferon α 2 combination

T2 - Ineffectiveness of a single six-week course in patients with metastatic renal cancer pretreated with interferon alone

AU - Pronzato, Paolo

PY - 1996

Y1 - 1996

N2 - We have studied activity and toxicity of subcutaneous recombinant interleukin-2 and interferon α 2b in a series of 14 patients with advanced renal cell carcinoma. No objective response was observed, and the median survival was 16 months (range 3-19); toxicity was acceptable. All the patients had poor prognostic factors and were pretreated with interferon.

AB - We have studied activity and toxicity of subcutaneous recombinant interleukin-2 and interferon α 2b in a series of 14 patients with advanced renal cell carcinoma. No objective response was observed, and the median survival was 16 months (range 3-19); toxicity was acceptable. All the patients had poor prognostic factors and were pretreated with interferon.

KW - interferon α

KW - interleukin-2

KW - renal cancer

UR - http://www.scopus.com/inward/record.url?scp=0029855083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029855083&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029855083

VL - 3

SP - 1137

EP - 1139

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 6

ER -

Interleukin-2 and interferon α 2 combination: Ineffectiveness of a single six-week course in patients with metastatic renal cancer pretreated with interferon alone

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this